- Home
- THW vs LXRX Comparison
THW vs LXRX Comparison
Compare THW & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THW
- LXRX
- Stock Information
- Founded
- THW 2015
- LXRX 1995
- Country
- THW United States
- LXRX United States
- Employees
- THW N/A
- LXRX N/A
- Industry
- THW Finance Companies
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- THW Finance
- LXRX Health Care
- Exchange
- THW Nasdaq
- LXRX Nasdaq
- Market Cap
- THW 473.6M
- LXRX 428.8M
- IPO Year
- THW N/A
- LXRX 2000
- Fundamental
- Price
- THW $12.98
- LXRX $1.46
- Analyst Decision
- THW
- LXRX Buy
- Analyst Count
- THW 0
- LXRX 5
- Target Price
- THW N/A
- LXRX $3.23
- AVG Volume (30 Days)
- THW 149.9K
- LXRX 3.2M
- Earning Date
- THW 01-01-0001
- LXRX 11-11-2025
- Dividend Yield
- THW 10.76%
- LXRX N/A
- EPS Growth
- THW N/A
- LXRX N/A
- EPS
- THW N/A
- LXRX N/A
- Revenue
- THW N/A
- LXRX $58,432,000.00
- Revenue This Year
- THW N/A
- LXRX $66.55
- Revenue Next Year
- THW N/A
- LXRX N/A
- P/E Ratio
- THW N/A
- LXRX N/A
- Revenue Growth
- THW N/A
- LXRX 1504.83
- 52 Week Low
- THW $9.76
- LXRX $0.28
- 52 Week High
- THW $14.89
- LXRX $2.18
- Technical
- Relative Strength Index (RSI)
- THW 70.57
- LXRX 56.13
- Support Level
- THW $12.72
- LXRX $1.40
- Resistance Level
- THW $13.05
- LXRX $1.66
- Average True Range (ATR)
- THW 0.23
- LXRX 0.12
- MACD
- THW 0.02
- LXRX 0.00
- Stochastic Oscillator
- THW 94.44
- LXRX 43.59
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies engaged in the healthcare industry. The company's investment portfolio comprises investments in different sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other areas. It also male into REIT Real Estate.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.